Monkey Research Reveals Long-Term Viability of Genetically Modified Pig Kidneys
2 min readScientists from the research organization eGenesis and Harvard Medical School have made significant progress in the field of xenotransplantation, or animal-to-human transplantation. In a recent study, they genetically engineered pigs to potentially improve the longevity of transplanted organs. The researchers bred Yucatan miniature pigs with up to 69 different genetic edits to make their organs more compatible with humans.
To test the effectiveness of these genetic changes, the scientists transplanted kidneys from these engineered pigs into monkeys. The results were promising, with some monkeys able to live for one to two years with the transplanted organs. This indicates that the genetic modifications made to the pigs could make pig-to-human transplants more feasible for clinical trials.
Organ shortages have been a major challenge in transplantation, and xenotransplantation has emerged as a potential solution. By editing the genes of pigs, scientists hope to create organs that can be tolerated by the recipient’s immune system. Previous tests in humans have shown that pig organs can be transplanted and remain functional for up to two months. However, for wider clinical trials, researchers argue that longer-term organ survival is essential.
The findings from this study are a proof-of-concept, bringing us one step closer to conducting clinical testing of porcine renal grafts for human transplantation. The monkeys receiving organs from the least-edited pigs only survived for less than two months on average. However, encouragingly, nine monkeys survived for longer than two months, five survived for over a year, and one monkey lived for just over two years. These results indicate the potential for long-term organ survival in future transplant experiments.
The success of these experiments highlights the importance of continued research in this field. Further large-scale clinical trials using pigs with organs capable of surviving longer-term tests will be necessary. If successful, xenotransplantation could provide a solution to the shortage of donated organs and potentially save countless lives.
As the researchers move forward, their focus will be on refining the genetic modifications and conducting additional experiments to ensure the safety and efficacy of pig-to-human organ transplantation. While there are still many challenges to overcome, these advancements bring us closer to a potential breakthrough in the field of transplantation.